SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 591, Pages eabd8836
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-04-29
DOI
10.1126/scitranslmed.abd8836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- The therapeutic landscape for cells engineered with chimeric antigen receptors
- (2020) Matthew MacKay et al. NATURE BIOTECHNOLOGY
- Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
- (2020) Fabio Nicolini et al. Frontiers in Oncology
- Immunotherapy in Malignant Pleural Mesothelioma
- (2020) Cornedine J. de Gooijer et al. Frontiers in Oncology
- Identification of ALPPL2 as a Naive Pluripotent State-Specific Surface Protein Essential for Human Naive Pluripotency Regulation
- (2020) Yan Bi et al. Cell Reports
- ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen
- (2020) Yang Su et al. CANCER RESEARCH
- Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies
- (2020) Ruth Dannenfelser et al. Cell Systems
- Immunotherapy Advances for Epithelial Ovarian Cancer
- (2020) Erin G. Hartnett et al. Cancers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
- (2019) Eric L. Smith et al. Science Translational Medicine
- Chimeric antigen receptor T cell persistence and memory cell formation
- (2019) Alexander D McLellan et al. IMMUNOLOGY AND CELL BIOLOGY
- Modulation of chimeric antigen receptor surface expression by a small molecule switch
- (2019) Alexandre Juillerat et al. BMC BIOTECHNOLOGY
- Updates on CAR T-cell therapy in B-cell malignancies
- (2019) Elad Jacoby et al. IMMUNOLOGICAL REVIEWS
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies
- (2018) Hui Luo et al. PLoS One
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
- (2018) Sophie Viaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
- (2017) Shingo Inaguma et al. Oncotarget
- Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
- (2017) Takashi Eguchi et al. Oncotarget
- Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent
- (2017) Diogo Gomes-Silva et al. Cell Reports
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
- (2016) Kole T. Roybal et al. CELL
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
- (2015) Prakash K. Gupta et al. PLoS Pathogens
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
- (2013) Petra C Schuberth et al. Journal of Translational Medicine
- Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
- (2012) Evripidis Lanitis et al. PLoS One
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma
- (2009) Scott Bidlingmaier et al. CANCER RESEARCH
- Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
- (2009) C. Sillaber et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
- (2009) Y. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens
- (2008) Fei Fei et al. EXPERIMENTAL HEMATOLOGY
- Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies
- (2008) F. An et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started